Fujifilm receives FDA clearance for Synapse 3D
Fujifilm Medical Systems’ Synapse 3D, which integrates directly into both Synapse PACS and Synapse Cardiovascular, without the need for separate workstations, is now FDA 510(k) cleared for sale in the U.S.

Synapse 3D can be used with virtually any advanced imaging system, such as PET, CT, MR and nuclear medicine. Because Synapse 3D is integrated directly into Synapse PACS and Synapse Cardiovascular, it is enterprise capable, and is available at any workstation where Synapse PACS is available, including at home or from remote locations, said the Stamford, Conn.-based company.